American Society for Microbiology, Journal of Virology, 18(95), 2021
DOI: 10.1128/jvi.00796-21
Full text: Download
PGT121 is a highly potent bNAb and its antiviral activities for HIV-1 prevention and therapy are currently being evaluated in clinical trials. The importance of its Fc-effector functions in clearing HIV-1-infected cells is also under investigation.